跳至主要内容
临床试验/2023-510208-39-00
2023-510208-39-00招募中2 期

Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年8月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100
试验地点
1
主要终点
18F-FAPI-74 PET/CT has a 70 % sensitivity in detecting metastatic lymph nodes

研究概览

简要总结

To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Primary or recurrent pancreatic cancer
  • Suspected primary or recurrent pancreatic cancer
  • Male or female aged 18-85 years
  • WHO performance score 0-2
  • Study subject signs informed consent form after receiving written information

排除标准

  • Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included
  • Study subject is not able to understand the purpose of the study
  • Medical conditions prohibiting whole-body PET/CT imaging

结局指标

主要结局

18F-FAPI-74 PET/CT has a 70 % sensitivity in detecting metastatic lymph nodes

18F-FAPI-74 PET/CT has a 70 % sensitivity in detecting metastatic lymph nodes

次要结局

未报告次要终点

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Saila Kauhanen

Scientific

Turku University Hospital

研究点 (1)

Loading locations...

相似试验